Chris Koumentakos
liked
$Arcutis Biotherapeutics (ARQT.US)$ shorties making it go down but such a strong company. Applaud 👏🏻👏🏻👏🏻
2
Chris Koumentakos
liked and commented on
$Arcutis Biotherapeutics (ARQT.US)$
I expect this to do well today based on its good ER results
I expect this to do well today based on its good ER results
4
3
Chris Koumentakos
commented on
$Arcutis Biotherapeutics (ARQT.US)$ anyone know why this stock is being murdered?
4
$ICZOOM Group (IZM.US)$ or maybe someone knows something we don’t. IN at $34.89.
1
Chris Koumentakos
liked
$ICZOOM Group (IZM.US)$ 7.270 to 52.210 amazing uptrend here worth keeping eye
1
Chris Koumentakos
liked
$Jiuzi (JZXN.US)$ everyone needs to buy the dip, 10$ next
3
2
Chris Koumentakos
liked
$Tempest Therapeutics (TPST.US)$
Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of care
-
Reported new biomarker data in two important subpopulations, PD-L1 negative and b-catenin mutant patients, consistent with MoA of TPST-1120
-
Preparing to move TPST-1120 into a pivotal Phase 3 trial in HCC and TPST-1495 into a Phase 2 in FAP
Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of care
-
Reported new biomarker data in two important subpopulations, PD-L1 negative and b-catenin mutant patients, consistent with MoA of TPST-1120
-
Preparing to move TPST-1120 into a pivotal Phase 3 trial in HCC and TPST-1495 into a Phase 2 in FAP
4
Chris Koumentakos
liked
$Tempest Therapeutics (TPST.US)$
3 different analysist have said this should go up to at least $12 with a high of 46.. hoping for the best!
3 different analysist have said this should go up to at least $12 with a high of 46.. hoping for the best!
2